This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jonathan D. C. Ross, MRCP(UK); Hugh Young, PhD, MRCPath
Edinburgh, Scotland

Arch Intern Med. 1994;154(22):2616.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Following the recent article by Jurado et al¹ regarding the prozone reaction in secondary syphilis, we would like to report our experience of the potential problems associated with the use of nontreponemal antibody tests to screen for treponemal infections.

Report of Cases. Case 1.

A 47-year-old man presented with a history of progressive cerebellar signs. There was no history of syphilis. The routine antitreponemal IgG enzyme immunoassay screening test (Captia Syphilis G) showed a positive result with an antibody index of 3.12. Confirmatory testing revealed a negative qualitative VDRL test result, a positive Treponema pallidum hemagglutination assay titer of 10 240, a positive fluorescent treponemal antibody absorbed test result, and a positive antitreponemal IgM enzyme immunoassay (Captia Syphilis M) with an antibody index of 1.2. Repeated VDRL testing, using diluted serum samples, gave a titer of 64, suggesting that the initial false-negative result was attributable to the prozone phenomenon . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?